| 5EW3: reference: Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis., Manley PW, Bold G, Bruggen J, Fendrich G, Furet P, Mestan J, Schnell C, Stolz B, Meyer T, Meyhack B, Stark W, Strauss A, Wood J, Biochim Biophys Acta. 2004 Mar 11;1697(1-2):17-27. PMID: 15023347 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).